Global Motorized Thrombectomy Devices Market

Motorized Thrombectomy Devices Comprehensive Study by Application (Brain and Neurological, Spine and Musculoskeletal, Abdominal, Coronary, Pulmonary), Architecture (Open Systems, Closed Systems), Field Strength (Low Field Strength, Mid Field Strength, High Field Strength), Diseases (Peripheral Diseases, Coronary Diseases, Neural Diseases, Others) Players and Region - Global Market Outlook to 2030

Motorized Thrombectomy Devices Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Motorized Thrombectomy Devices
Motorized Thrombectomy Devices are defined as the interventional procedure of removing a blood clot from a blood vessel. The types of thrombectomy systems include thrombus fragmentation, aspiration thrombectomy, rotational embolectomy, rheolytic embolectomy, ultrasound-assisted thrombolysis and others. It is used in various applications such as Brain and neurological, spine and musculoskeletal, abdominal, coronary, pulmonary and others.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The global motorized thrombectomy devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Motorized Thrombectomy Devices market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Medtronic plc (Ireland), Bayer AG (Germany), Johnson & Johnson Inc. (Canada), Boston Scientific Corporation (United States), Stryker Corporation (United States), Teleflex Incorporated (United States), Terumo Corporation (Japan), Penumbra Inc. (United States), The Spectranetics Corporation (United States) and AngioDynamics, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Vascular Solutions, Inc. (United States).

Segmentation Overview
AMA Research has segmented the market of Global Motorized Thrombectomy Devices market by , Application (Brain and Neurological, Spine and Musculoskeletal, Abdominal, Coronary and Pulmonary) and Region.



On the basis of geography, the market of Motorized Thrombectomy Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Architecture, the sub-segment i.e. Open Systems will boost the Motorized Thrombectomy Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Field Strength, the sub-segment i.e. Low Field Strength will boost the Motorized Thrombectomy Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Diseases, the sub-segment i.e. Peripheral Diseases will boost the Motorized Thrombectomy Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technology Advancement in Motorized Thrombectomy Devices

Market Growth Drivers:
Increase in the incidence of chronic diseases owing to the sedentary lifestyle. For instance, in 2013, as per an article published by the American Lung Association (ALA), COPD is the 3rd leading cause of death in the United States. Furthermore, more than 11 million people have been diagnosed with COPD. Hence, this has led to witness the growth of the global motorized thrombectomy devices market during the forecast period.

Challenges:
Some of the major problems related to the high cost of devices and complicated use of thrombectomy devices could be challenges for market growth and Dearth of skilled & well-trained surgeons to perform thrombectomy procedures

Restraints:
Stringent Rules and Regulation

Opportunities:
Increasing in geriatric population in the APAC region. For instance, China’s aging working population presents a serious economic problem. In 2015, for instance, according to the Center for Strategic and International Studies, more than 9.5% of the population of China was aged 65 or older in 2015. In addition, The UN projected that it will reach 27.5% by 2050. Hence, it will create new opportunities for market expansion.

Market Leaders and their expansionary development strategies
In September 2021, Boston Scientific Corporation announced an agreement to acquire Devoro Medical, Inc., developer of the WOLF Thrombectomy Platform. The innovative non-console and lytic-free WOLF technology targets and rapidly captures blood clots using finger-like prongs that retrieve and remove thrombi in the arterial and venous systems.
In June 2021, Bayer AG, a German multinational pharmaceutical and life sciences company, has decided to grow its business prospects in India due to the increasing demand for pharmaceuticals in the country by focusing its business operations on 10 brands including headache relief medicine Saridon, multivitamin Supradyn, antifungal Canesten and anti-allergy drug Alaspan, to conquer the Indian market.


Key Target Audience
Motorized Thrombectomy Devices Companies, Research and Development (R&D) Companies, Research Organization, Federal Agencies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Brain and Neurological
  • Spine and Musculoskeletal
  • Abdominal
  • Coronary
  • Pulmonary
By Architecture
  • Open Systems
  • Closed Systems

By Field Strength
  • Low Field Strength
  • Mid Field Strength
  • High Field Strength

By Diseases
  • Peripheral Diseases
  • Coronary Diseases
  • Neural Diseases
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the incidence of chronic diseases owing to the sedentary lifestyle. For instance, in 2013, as per an article published by the American Lung Association (ALA), COPD is the 3rd leading cause of death in the United States. Furthermore, more than 11 million people have been diagnosed with COPD. Hence, this has led to witness the growth of the global motorized thrombectomy devices market during the forecast period.
    • 3.3. Market Challenges
      • 3.3.1. Some of the major problems related to the high cost of devices and complicated use of thrombectomy devices could be challenges for market growth
      • 3.3.2. Dearth of skilled & well-trained surgeons to perform thrombectomy procedures
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement in Motorized Thrombectomy Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Motorized Thrombectomy Devices, by Application, Architecture, Field Strength, Diseases and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Motorized Thrombectomy Devices (Value)
      • 5.2.1. Global Motorized Thrombectomy Devices by: Application (Value)
        • 5.2.1.1. Brain and Neurological
        • 5.2.1.2. Spine and Musculoskeletal
        • 5.2.1.3. Abdominal
        • 5.2.1.4. Coronary
        • 5.2.1.5. Pulmonary
      • 5.2.2. Global Motorized Thrombectomy Devices by: Architecture (Value)
        • 5.2.2.1. Open Systems
        • 5.2.2.2. Closed Systems
      • 5.2.3. Global Motorized Thrombectomy Devices by: Field Strength (Value)
        • 5.2.3.1. Low Field Strength
        • 5.2.3.2. Mid Field Strength
        • 5.2.3.3. High Field Strength
      • 5.2.4. Global Motorized Thrombectomy Devices by: Diseases (Value)
        • 5.2.4.1. Peripheral Diseases
        • 5.2.4.2. Coronary Diseases
        • 5.2.4.3. Neural Diseases
        • 5.2.4.4. Others
      • 5.2.5. Global Motorized Thrombectomy Devices Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Motorized Thrombectomy Devices (Volume)
      • 5.3.1. Global Motorized Thrombectomy Devices by: Application (Volume)
        • 5.3.1.1. Brain and Neurological
        • 5.3.1.2. Spine and Musculoskeletal
        • 5.3.1.3. Abdominal
        • 5.3.1.4. Coronary
        • 5.3.1.5. Pulmonary
      • 5.3.2. Global Motorized Thrombectomy Devices by: Architecture (Volume)
        • 5.3.2.1. Open Systems
        • 5.3.2.2. Closed Systems
      • 5.3.3. Global Motorized Thrombectomy Devices by: Field Strength (Volume)
        • 5.3.3.1. Low Field Strength
        • 5.3.3.2. Mid Field Strength
        • 5.3.3.3. High Field Strength
      • 5.3.4. Global Motorized Thrombectomy Devices by: Diseases (Volume)
        • 5.3.4.1. Peripheral Diseases
        • 5.3.4.2. Coronary Diseases
        • 5.3.4.3. Neural Diseases
        • 5.3.4.4. Others
      • 5.3.5. Global Motorized Thrombectomy Devices Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Motorized Thrombectomy Devices (Price)
  • 6. Motorized Thrombectomy Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic plc (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bayer AG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Johnson & Johnson Inc. (Canada)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Boston Scientific Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Stryker Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Teleflex Incorporated (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Terumo Corporation (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Penumbra Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. The Spectranetics Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. AngioDynamics, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Motorized Thrombectomy Devices Sale, by Application, Architecture, Field Strength, Diseases and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Motorized Thrombectomy Devices (Value)
      • 7.2.1. Global Motorized Thrombectomy Devices by: Application (Value)
        • 7.2.1.1. Brain and Neurological
        • 7.2.1.2. Spine and Musculoskeletal
        • 7.2.1.3. Abdominal
        • 7.2.1.4. Coronary
        • 7.2.1.5. Pulmonary
      • 7.2.2. Global Motorized Thrombectomy Devices by: Architecture (Value)
        • 7.2.2.1. Open Systems
        • 7.2.2.2. Closed Systems
      • 7.2.3. Global Motorized Thrombectomy Devices by: Field Strength (Value)
        • 7.2.3.1. Low Field Strength
        • 7.2.3.2. Mid Field Strength
        • 7.2.3.3. High Field Strength
      • 7.2.4. Global Motorized Thrombectomy Devices by: Diseases (Value)
        • 7.2.4.1. Peripheral Diseases
        • 7.2.4.2. Coronary Diseases
        • 7.2.4.3. Neural Diseases
        • 7.2.4.4. Others
      • 7.2.5. Global Motorized Thrombectomy Devices Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Motorized Thrombectomy Devices (Volume)
      • 7.3.1. Global Motorized Thrombectomy Devices by: Application (Volume)
        • 7.3.1.1. Brain and Neurological
        • 7.3.1.2. Spine and Musculoskeletal
        • 7.3.1.3. Abdominal
        • 7.3.1.4. Coronary
        • 7.3.1.5. Pulmonary
      • 7.3.2. Global Motorized Thrombectomy Devices by: Architecture (Volume)
        • 7.3.2.1. Open Systems
        • 7.3.2.2. Closed Systems
      • 7.3.3. Global Motorized Thrombectomy Devices by: Field Strength (Volume)
        • 7.3.3.1. Low Field Strength
        • 7.3.3.2. Mid Field Strength
        • 7.3.3.3. High Field Strength
      • 7.3.4. Global Motorized Thrombectomy Devices by: Diseases (Volume)
        • 7.3.4.1. Peripheral Diseases
        • 7.3.4.2. Coronary Diseases
        • 7.3.4.3. Neural Diseases
        • 7.3.4.4. Others
      • 7.3.5. Global Motorized Thrombectomy Devices Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Motorized Thrombectomy Devices (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Motorized Thrombectomy Devices: by Application(USD Million)
  • Table 2. Motorized Thrombectomy Devices Brain and Neurological , by Region USD Million (2018-2023)
  • Table 3. Motorized Thrombectomy Devices Spine and Musculoskeletal , by Region USD Million (2018-2023)
  • Table 4. Motorized Thrombectomy Devices Abdominal , by Region USD Million (2018-2023)
  • Table 5. Motorized Thrombectomy Devices Coronary , by Region USD Million (2018-2023)
  • Table 6. Motorized Thrombectomy Devices Pulmonary , by Region USD Million (2018-2023)
  • Table 7. Motorized Thrombectomy Devices: by Architecture(USD Million)
  • Table 8. Motorized Thrombectomy Devices Open Systems , by Region USD Million (2018-2023)
  • Table 9. Motorized Thrombectomy Devices Closed Systems , by Region USD Million (2018-2023)
  • Table 10. Motorized Thrombectomy Devices: by Field Strength(USD Million)
  • Table 11. Motorized Thrombectomy Devices Low Field Strength , by Region USD Million (2018-2023)
  • Table 12. Motorized Thrombectomy Devices Mid Field Strength , by Region USD Million (2018-2023)
  • Table 13. Motorized Thrombectomy Devices High Field Strength , by Region USD Million (2018-2023)
  • Table 14. Motorized Thrombectomy Devices: by Diseases(USD Million)
  • Table 15. Motorized Thrombectomy Devices Peripheral Diseases , by Region USD Million (2018-2023)
  • Table 16. Motorized Thrombectomy Devices Coronary Diseases , by Region USD Million (2018-2023)
  • Table 17. Motorized Thrombectomy Devices Neural Diseases , by Region USD Million (2018-2023)
  • Table 18. Motorized Thrombectomy Devices Others , by Region USD Million (2018-2023)
  • Table 19. South America Motorized Thrombectomy Devices, by Country USD Million (2018-2023)
  • Table 20. South America Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 21. South America Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 22. South America Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 23. South America Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 24. Brazil Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 25. Brazil Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 26. Brazil Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 27. Brazil Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 28. Argentina Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 29. Argentina Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 30. Argentina Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 31. Argentina Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 32. Rest of South America Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 33. Rest of South America Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 34. Rest of South America Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 35. Rest of South America Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 36. Asia Pacific Motorized Thrombectomy Devices, by Country USD Million (2018-2023)
  • Table 37. Asia Pacific Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 38. Asia Pacific Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 39. Asia Pacific Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 40. Asia Pacific Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 41. China Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 42. China Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 43. China Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 44. China Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 45. Japan Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 46. Japan Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 47. Japan Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 48. Japan Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 49. India Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 50. India Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 51. India Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 52. India Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 53. South Korea Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 54. South Korea Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 55. South Korea Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 56. South Korea Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 57. Taiwan Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 58. Taiwan Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 59. Taiwan Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 60. Taiwan Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 61. Australia Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 62. Australia Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 63. Australia Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 64. Australia Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 69. Europe Motorized Thrombectomy Devices, by Country USD Million (2018-2023)
  • Table 70. Europe Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 71. Europe Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 72. Europe Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 73. Europe Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 74. Germany Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 75. Germany Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 76. Germany Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 77. Germany Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 78. France Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 79. France Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 80. France Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 81. France Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 82. Italy Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 83. Italy Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 84. Italy Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 85. Italy Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 86. United Kingdom Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 87. United Kingdom Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 88. United Kingdom Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 89. United Kingdom Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 90. Netherlands Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 91. Netherlands Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 92. Netherlands Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 93. Netherlands Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 94. Rest of Europe Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 95. Rest of Europe Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 96. Rest of Europe Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 97. Rest of Europe Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 98. MEA Motorized Thrombectomy Devices, by Country USD Million (2018-2023)
  • Table 99. MEA Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 100. MEA Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 101. MEA Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 102. MEA Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 103. Middle East Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 104. Middle East Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 105. Middle East Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 106. Middle East Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 107. Africa Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 108. Africa Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 109. Africa Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 110. Africa Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 111. North America Motorized Thrombectomy Devices, by Country USD Million (2018-2023)
  • Table 112. North America Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 113. North America Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 114. North America Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 115. North America Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 116. United States Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 117. United States Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 118. United States Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 119. United States Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 120. Canada Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 121. Canada Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 122. Canada Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 123. Canada Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 124. Mexico Motorized Thrombectomy Devices, by Application USD Million (2018-2023)
  • Table 125. Mexico Motorized Thrombectomy Devices, by Architecture USD Million (2018-2023)
  • Table 126. Mexico Motorized Thrombectomy Devices, by Field Strength USD Million (2018-2023)
  • Table 127. Mexico Motorized Thrombectomy Devices, by Diseases USD Million (2018-2023)
  • Table 128. Motorized Thrombectomy Devices Sales: by Application(M Units)
  • Table 129. Motorized Thrombectomy Devices Sales Brain and Neurological , by Region M Units (2018-2023)
  • Table 130. Motorized Thrombectomy Devices Sales Spine and Musculoskeletal , by Region M Units (2018-2023)
  • Table 131. Motorized Thrombectomy Devices Sales Abdominal , by Region M Units (2018-2023)
  • Table 132. Motorized Thrombectomy Devices Sales Coronary , by Region M Units (2018-2023)
  • Table 133. Motorized Thrombectomy Devices Sales Pulmonary , by Region M Units (2018-2023)
  • Table 134. Motorized Thrombectomy Devices Sales: by Architecture(M Units)
  • Table 135. Motorized Thrombectomy Devices Sales Open Systems , by Region M Units (2018-2023)
  • Table 136. Motorized Thrombectomy Devices Sales Closed Systems , by Region M Units (2018-2023)
  • Table 137. Motorized Thrombectomy Devices Sales: by Field Strength(M Units)
  • Table 138. Motorized Thrombectomy Devices Sales Low Field Strength , by Region M Units (2018-2023)
  • Table 139. Motorized Thrombectomy Devices Sales Mid Field Strength , by Region M Units (2018-2023)
  • Table 140. Motorized Thrombectomy Devices Sales High Field Strength , by Region M Units (2018-2023)
  • Table 141. Motorized Thrombectomy Devices Sales: by Diseases(M Units)
  • Table 142. Motorized Thrombectomy Devices Sales Peripheral Diseases , by Region M Units (2018-2023)
  • Table 143. Motorized Thrombectomy Devices Sales Coronary Diseases , by Region M Units (2018-2023)
  • Table 144. Motorized Thrombectomy Devices Sales Neural Diseases , by Region M Units (2018-2023)
  • Table 145. Motorized Thrombectomy Devices Sales Others , by Region M Units (2018-2023)
  • Table 146. South America Motorized Thrombectomy Devices Sales, by Country M Units (2018-2023)
  • Table 147. South America Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 148. South America Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 149. South America Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 150. South America Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 151. Brazil Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 152. Brazil Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 153. Brazil Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 154. Brazil Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 155. Argentina Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 156. Argentina Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 157. Argentina Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 158. Argentina Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 159. Rest of South America Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 160. Rest of South America Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 161. Rest of South America Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 162. Rest of South America Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 163. Asia Pacific Motorized Thrombectomy Devices Sales, by Country M Units (2018-2023)
  • Table 164. Asia Pacific Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 165. Asia Pacific Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 166. Asia Pacific Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 167. Asia Pacific Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 168. China Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 169. China Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 170. China Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 171. China Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 172. Japan Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 173. Japan Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 174. Japan Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 175. Japan Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 176. India Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 177. India Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 178. India Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 179. India Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 180. South Korea Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 181. South Korea Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 182. South Korea Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 183. South Korea Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 184. Taiwan Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 185. Taiwan Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 186. Taiwan Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 187. Taiwan Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 188. Australia Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 189. Australia Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 190. Australia Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 191. Australia Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 192. Rest of Asia-Pacific Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 193. Rest of Asia-Pacific Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 194. Rest of Asia-Pacific Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 195. Rest of Asia-Pacific Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 196. Europe Motorized Thrombectomy Devices Sales, by Country M Units (2018-2023)
  • Table 197. Europe Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 198. Europe Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 199. Europe Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 200. Europe Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 201. Germany Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 202. Germany Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 203. Germany Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 204. Germany Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 205. France Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 206. France Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 207. France Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 208. France Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 209. Italy Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 210. Italy Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 211. Italy Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 212. Italy Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 213. United Kingdom Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 214. United Kingdom Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 215. United Kingdom Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 216. United Kingdom Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 217. Netherlands Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 218. Netherlands Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 219. Netherlands Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 220. Netherlands Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 221. Rest of Europe Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 222. Rest of Europe Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 223. Rest of Europe Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 224. Rest of Europe Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 225. MEA Motorized Thrombectomy Devices Sales, by Country M Units (2018-2023)
  • Table 226. MEA Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 227. MEA Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 228. MEA Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 229. MEA Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 230. Middle East Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 231. Middle East Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 232. Middle East Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 233. Middle East Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 234. Africa Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 235. Africa Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 236. Africa Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 237. Africa Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 238. North America Motorized Thrombectomy Devices Sales, by Country M Units (2018-2023)
  • Table 239. North America Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 240. North America Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 241. North America Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 242. North America Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 243. United States Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 244. United States Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 245. United States Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 246. United States Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 247. Canada Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 248. Canada Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 249. Canada Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 250. Canada Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 251. Mexico Motorized Thrombectomy Devices Sales, by Application M Units (2018-2023)
  • Table 252. Mexico Motorized Thrombectomy Devices Sales, by Architecture M Units (2018-2023)
  • Table 253. Mexico Motorized Thrombectomy Devices Sales, by Field Strength M Units (2018-2023)
  • Table 254. Mexico Motorized Thrombectomy Devices Sales, by Diseases M Units (2018-2023)
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Motorized Thrombectomy Devices: by Application(USD Million)
  • Table 266. Motorized Thrombectomy Devices Brain and Neurological , by Region USD Million (2025-2030)
  • Table 267. Motorized Thrombectomy Devices Spine and Musculoskeletal , by Region USD Million (2025-2030)
  • Table 268. Motorized Thrombectomy Devices Abdominal , by Region USD Million (2025-2030)
  • Table 269. Motorized Thrombectomy Devices Coronary , by Region USD Million (2025-2030)
  • Table 270. Motorized Thrombectomy Devices Pulmonary , by Region USD Million (2025-2030)
  • Table 271. Motorized Thrombectomy Devices: by Architecture(USD Million)
  • Table 272. Motorized Thrombectomy Devices Open Systems , by Region USD Million (2025-2030)
  • Table 273. Motorized Thrombectomy Devices Closed Systems , by Region USD Million (2025-2030)
  • Table 274. Motorized Thrombectomy Devices: by Field Strength(USD Million)
  • Table 275. Motorized Thrombectomy Devices Low Field Strength , by Region USD Million (2025-2030)
  • Table 276. Motorized Thrombectomy Devices Mid Field Strength , by Region USD Million (2025-2030)
  • Table 277. Motorized Thrombectomy Devices High Field Strength , by Region USD Million (2025-2030)
  • Table 278. Motorized Thrombectomy Devices: by Diseases(USD Million)
  • Table 279. Motorized Thrombectomy Devices Peripheral Diseases , by Region USD Million (2025-2030)
  • Table 280. Motorized Thrombectomy Devices Coronary Diseases , by Region USD Million (2025-2030)
  • Table 281. Motorized Thrombectomy Devices Neural Diseases , by Region USD Million (2025-2030)
  • Table 282. Motorized Thrombectomy Devices Others , by Region USD Million (2025-2030)
  • Table 283. South America Motorized Thrombectomy Devices, by Country USD Million (2025-2030)
  • Table 284. South America Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 285. South America Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 286. South America Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 287. South America Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 288. Brazil Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 289. Brazil Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 290. Brazil Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 291. Brazil Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 292. Argentina Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 293. Argentina Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 294. Argentina Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 295. Argentina Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 296. Rest of South America Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 297. Rest of South America Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 298. Rest of South America Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 299. Rest of South America Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 300. Asia Pacific Motorized Thrombectomy Devices, by Country USD Million (2025-2030)
  • Table 301. Asia Pacific Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 302. Asia Pacific Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 303. Asia Pacific Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 304. Asia Pacific Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 305. China Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 306. China Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 307. China Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 308. China Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 309. Japan Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 310. Japan Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 311. Japan Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 312. Japan Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 313. India Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 314. India Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 315. India Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 316. India Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 317. South Korea Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 318. South Korea Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 319. South Korea Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 320. South Korea Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 321. Taiwan Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 322. Taiwan Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 323. Taiwan Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 324. Taiwan Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 325. Australia Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 326. Australia Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 327. Australia Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 328. Australia Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 329. Rest of Asia-Pacific Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 330. Rest of Asia-Pacific Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 331. Rest of Asia-Pacific Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 332. Rest of Asia-Pacific Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 333. Europe Motorized Thrombectomy Devices, by Country USD Million (2025-2030)
  • Table 334. Europe Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 335. Europe Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 336. Europe Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 337. Europe Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 338. Germany Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 339. Germany Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 340. Germany Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 341. Germany Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 342. France Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 343. France Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 344. France Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 345. France Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 346. Italy Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 347. Italy Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 348. Italy Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 349. Italy Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 350. United Kingdom Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 351. United Kingdom Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 352. United Kingdom Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 353. United Kingdom Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 354. Netherlands Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 355. Netherlands Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 356. Netherlands Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 357. Netherlands Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 358. Rest of Europe Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 359. Rest of Europe Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 360. Rest of Europe Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 361. Rest of Europe Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 362. MEA Motorized Thrombectomy Devices, by Country USD Million (2025-2030)
  • Table 363. MEA Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 364. MEA Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 365. MEA Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 366. MEA Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 367. Middle East Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 368. Middle East Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 369. Middle East Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 370. Middle East Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 371. Africa Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 372. Africa Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 373. Africa Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 374. Africa Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 375. North America Motorized Thrombectomy Devices, by Country USD Million (2025-2030)
  • Table 376. North America Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 377. North America Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 378. North America Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 379. North America Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 380. United States Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 381. United States Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 382. United States Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 383. United States Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 384. Canada Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 385. Canada Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 386. Canada Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 387. Canada Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 388. Mexico Motorized Thrombectomy Devices, by Application USD Million (2025-2030)
  • Table 389. Mexico Motorized Thrombectomy Devices, by Architecture USD Million (2025-2030)
  • Table 390. Mexico Motorized Thrombectomy Devices, by Field Strength USD Million (2025-2030)
  • Table 391. Mexico Motorized Thrombectomy Devices, by Diseases USD Million (2025-2030)
  • Table 392. Motorized Thrombectomy Devices Sales: by Application(M Units)
  • Table 393. Motorized Thrombectomy Devices Sales Brain and Neurological , by Region M Units (2025-2030)
  • Table 394. Motorized Thrombectomy Devices Sales Spine and Musculoskeletal , by Region M Units (2025-2030)
  • Table 395. Motorized Thrombectomy Devices Sales Abdominal , by Region M Units (2025-2030)
  • Table 396. Motorized Thrombectomy Devices Sales Coronary , by Region M Units (2025-2030)
  • Table 397. Motorized Thrombectomy Devices Sales Pulmonary , by Region M Units (2025-2030)
  • Table 398. Motorized Thrombectomy Devices Sales: by Architecture(M Units)
  • Table 399. Motorized Thrombectomy Devices Sales Open Systems , by Region M Units (2025-2030)
  • Table 400. Motorized Thrombectomy Devices Sales Closed Systems , by Region M Units (2025-2030)
  • Table 401. Motorized Thrombectomy Devices Sales: by Field Strength(M Units)
  • Table 402. Motorized Thrombectomy Devices Sales Low Field Strength , by Region M Units (2025-2030)
  • Table 403. Motorized Thrombectomy Devices Sales Mid Field Strength , by Region M Units (2025-2030)
  • Table 404. Motorized Thrombectomy Devices Sales High Field Strength , by Region M Units (2025-2030)
  • Table 405. Motorized Thrombectomy Devices Sales: by Diseases(M Units)
  • Table 406. Motorized Thrombectomy Devices Sales Peripheral Diseases , by Region M Units (2025-2030)
  • Table 407. Motorized Thrombectomy Devices Sales Coronary Diseases , by Region M Units (2025-2030)
  • Table 408. Motorized Thrombectomy Devices Sales Neural Diseases , by Region M Units (2025-2030)
  • Table 409. Motorized Thrombectomy Devices Sales Others , by Region M Units (2025-2030)
  • Table 410. South America Motorized Thrombectomy Devices Sales, by Country M Units (2025-2030)
  • Table 411. South America Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 412. South America Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 413. South America Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 414. South America Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 415. Brazil Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 416. Brazil Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 417. Brazil Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 418. Brazil Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 419. Argentina Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 420. Argentina Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 421. Argentina Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 422. Argentina Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 423. Rest of South America Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 424. Rest of South America Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 425. Rest of South America Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 426. Rest of South America Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 427. Asia Pacific Motorized Thrombectomy Devices Sales, by Country M Units (2025-2030)
  • Table 428. Asia Pacific Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 429. Asia Pacific Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 430. Asia Pacific Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 431. Asia Pacific Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 432. China Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 433. China Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 434. China Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 435. China Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 436. Japan Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 437. Japan Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 438. Japan Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 439. Japan Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 440. India Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 441. India Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 442. India Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 443. India Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 444. South Korea Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 445. South Korea Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 446. South Korea Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 447. South Korea Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 448. Taiwan Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 449. Taiwan Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 450. Taiwan Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 451. Taiwan Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 452. Australia Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 453. Australia Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 454. Australia Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 455. Australia Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 456. Rest of Asia-Pacific Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 457. Rest of Asia-Pacific Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 458. Rest of Asia-Pacific Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 459. Rest of Asia-Pacific Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 460. Europe Motorized Thrombectomy Devices Sales, by Country M Units (2025-2030)
  • Table 461. Europe Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 462. Europe Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 463. Europe Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 464. Europe Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 465. Germany Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 466. Germany Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 467. Germany Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 468. Germany Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 469. France Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 470. France Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 471. France Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 472. France Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 473. Italy Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 474. Italy Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 475. Italy Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 476. Italy Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 477. United Kingdom Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 478. United Kingdom Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 479. United Kingdom Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 480. United Kingdom Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 481. Netherlands Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 482. Netherlands Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 483. Netherlands Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 484. Netherlands Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 485. Rest of Europe Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 486. Rest of Europe Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 487. Rest of Europe Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 488. Rest of Europe Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 489. MEA Motorized Thrombectomy Devices Sales, by Country M Units (2025-2030)
  • Table 490. MEA Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 491. MEA Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 492. MEA Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 493. MEA Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 494. Middle East Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 495. Middle East Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 496. Middle East Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 497. Middle East Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 498. Africa Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 499. Africa Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 500. Africa Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 501. Africa Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 502. North America Motorized Thrombectomy Devices Sales, by Country M Units (2025-2030)
  • Table 503. North America Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 504. North America Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 505. North America Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 506. North America Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 507. United States Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 508. United States Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 509. United States Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 510. United States Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 511. Canada Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 512. Canada Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 513. Canada Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 514. Canada Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 515. Mexico Motorized Thrombectomy Devices Sales, by Application M Units (2025-2030)
  • Table 516. Mexico Motorized Thrombectomy Devices Sales, by Architecture M Units (2025-2030)
  • Table 517. Mexico Motorized Thrombectomy Devices Sales, by Field Strength M Units (2025-2030)
  • Table 518. Mexico Motorized Thrombectomy Devices Sales, by Diseases M Units (2025-2030)
  • Table 519. Research Programs/Design for This Report
  • Table 520. Key Data Information from Secondary Sources
  • Table 521. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Motorized Thrombectomy Devices: by Application USD Million (2018-2023)
  • Figure 5. Global Motorized Thrombectomy Devices: by Architecture USD Million (2018-2023)
  • Figure 6. Global Motorized Thrombectomy Devices: by Field Strength USD Million (2018-2023)
  • Figure 7. Global Motorized Thrombectomy Devices: by Diseases USD Million (2018-2023)
  • Figure 8. South America Motorized Thrombectomy Devices Share (%), by Country
  • Figure 9. Asia Pacific Motorized Thrombectomy Devices Share (%), by Country
  • Figure 10. Europe Motorized Thrombectomy Devices Share (%), by Country
  • Figure 11. MEA Motorized Thrombectomy Devices Share (%), by Country
  • Figure 12. North America Motorized Thrombectomy Devices Share (%), by Country
  • Figure 13. Global Motorized Thrombectomy Devices: by Application M Units (2018-2023)
  • Figure 14. Global Motorized Thrombectomy Devices: by Architecture M Units (2018-2023)
  • Figure 15. Global Motorized Thrombectomy Devices: by Field Strength M Units (2018-2023)
  • Figure 16. Global Motorized Thrombectomy Devices: by Diseases M Units (2018-2023)
  • Figure 17. South America Motorized Thrombectomy Devices Share (%), by Country
  • Figure 18. Asia Pacific Motorized Thrombectomy Devices Share (%), by Country
  • Figure 19. Europe Motorized Thrombectomy Devices Share (%), by Country
  • Figure 20. MEA Motorized Thrombectomy Devices Share (%), by Country
  • Figure 21. North America Motorized Thrombectomy Devices Share (%), by Country
  • Figure 22. Global Motorized Thrombectomy Devices share by Players 2023 (%)
  • Figure 23. Global Motorized Thrombectomy Devices share by Players (Top 3) 2023(%)
  • Figure 24. Global Motorized Thrombectomy Devices share by Players (Top 5) 2023(%)
  • Figure 25. BCG Matrix for key Companies
  • Figure 26. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 27. Medtronic plc (Ireland) Revenue: by Geography 2023
  • Figure 28. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Bayer AG (Germany) Revenue: by Geography 2023
  • Figure 30. Johnson & Johnson Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 31. Johnson & Johnson Inc. (Canada) Revenue: by Geography 2023
  • Figure 32. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. Boston Scientific Corporation (United States) Revenue: by Geography 2023
  • Figure 34. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 35. Stryker Corporation (United States) Revenue: by Geography 2023
  • Figure 36. Teleflex Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 37. Teleflex Incorporated (United States) Revenue: by Geography 2023
  • Figure 38. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 39. Terumo Corporation (Japan) Revenue: by Geography 2023
  • Figure 40. Penumbra Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 41. Penumbra Inc. (United States) Revenue: by Geography 2023
  • Figure 42. The Spectranetics Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 43. The Spectranetics Corporation (United States) Revenue: by Geography 2023
  • Figure 44. AngioDynamics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 45. AngioDynamics, Inc. (United States) Revenue: by Geography 2023
  • Figure 46. Global Motorized Thrombectomy Devices: by Application USD Million (2025-2030)
  • Figure 47. Global Motorized Thrombectomy Devices: by Architecture USD Million (2025-2030)
  • Figure 48. Global Motorized Thrombectomy Devices: by Field Strength USD Million (2025-2030)
  • Figure 49. Global Motorized Thrombectomy Devices: by Diseases USD Million (2025-2030)
  • Figure 50. South America Motorized Thrombectomy Devices Share (%), by Country
  • Figure 51. Asia Pacific Motorized Thrombectomy Devices Share (%), by Country
  • Figure 52. Europe Motorized Thrombectomy Devices Share (%), by Country
  • Figure 53. MEA Motorized Thrombectomy Devices Share (%), by Country
  • Figure 54. North America Motorized Thrombectomy Devices Share (%), by Country
  • Figure 55. Global Motorized Thrombectomy Devices: by Application M Units (2025-2030)
  • Figure 56. Global Motorized Thrombectomy Devices: by Architecture M Units (2025-2030)
  • Figure 57. Global Motorized Thrombectomy Devices: by Field Strength M Units (2025-2030)
  • Figure 58. Global Motorized Thrombectomy Devices: by Diseases M Units (2025-2030)
  • Figure 59. South America Motorized Thrombectomy Devices Share (%), by Country
  • Figure 60. Asia Pacific Motorized Thrombectomy Devices Share (%), by Country
  • Figure 61. Europe Motorized Thrombectomy Devices Share (%), by Country
  • Figure 62. MEA Motorized Thrombectomy Devices Share (%), by Country
  • Figure 63. North America Motorized Thrombectomy Devices Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Medtronic plc (Ireland)
  • Bayer AG (Germany)
  • Johnson & Johnson Inc. (Canada)
  • Boston Scientific Corporation (United States)
  • Stryker Corporation (United States)
  • Teleflex Incorporated (United States)
  • Terumo Corporation (Japan)
  • Penumbra Inc. (United States)
  • The Spectranetics Corporation (United States)
  • AngioDynamics, Inc. (United States)
Additional players considered in the study are as follows:
Vascular Solutions, Inc. (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 158 Pages 70 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Motorized Thrombectomy Devices Market Quantitative research analysis
Global Motorized Thrombectomy Devices Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Medtronic plc (Ireland), Bayer AG (Germany), Johnson & Johnson Inc. (Canada), Boston Scientific Corporation (United States), Stryker Corporation (United States), Teleflex Incorporated (United States), Terumo Corporation (Japan), Penumbra Inc. (United States), The Spectranetics Corporation (United States) and AngioDynamics, Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technology Advancement in Motorized Thrombectomy Devices" is seen as one of major influencing trends for Motorized Thrombectomy Devices Market during projected period 2023-2030.
The Motorized Thrombectomy Devices market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Motorized Thrombectomy Devices Market Report?

Have a Query? Click Here

Other Related Reports

Huber Needle Comprehensive Study by Type (Safety Huber Needle {Needle-free Injection Site and Open Y-Injection Site}, Standard Huber Needle), Application (Critical Care, Obstetrics Neonatology Entera...
$ 3750
Tissue Testing Comprehensive Study by Type (Consumables {Antibodies, Kits, Reagents, Probes}, Instruments {Slide-staining systems, Scanners, Tissue-processing systems, other instruments}), Applicatio...
$ 3750
Gel Dryer Comprehensive Study by Application (Biotech Companies, Pharmaceutical Companies), Devices (Gel Dryer Device, Vacuum Pump), Offering (Software, Hardware), Systems (Passive Evaporation (Air-D...
$ 3350
Medical Skull Comprehensive Study by Type (Human, Animal), Application (Training, Dental, Surgery, Pathology, Treatment), End Users (Schools and Universities, Home Educators, Hospitals and Healthcare...
$ 3750
Laser Microdisection Comprehensive Study by Application (Molecular Biology, Cell Biology, Forensic Science), End-user (Academic and Government Research Institutes, Hospitals, Pharmaceutical and Biote...
$ 3750
Intracardiac Imaging Comprehensive Study by Type (Intracardiac Echo, Transthoracic Echo, Transesophageal (TEE) Imaging, Intravascular Ultrasound (IVUS), Optical Coherence Tomography (OCT)), Applicati...
$ 3750